News
-
-
PRESS RELEASE
CTT Pharma Gives Update On U.S. and European Patents
CTT Pharmaceutical Holdings, Inc. receives intention to grant additional claims for diabetes drug patent from European Patent Office and plans to utilize micelle technology for enhanced drug delivery. Seeking opportunities for pharmaceutical companies -
-
-
-
PRESS RELEASE
CTT Pharma Adds Independent Director With NIH/NSF Experience
CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT -
-
-
-